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The aorta-gonad-mesonephros (AGM) region 
is an organ with complex cellular architecture 
in which hematopoietic stem cells (HSCs) ma-
ture during a narrow time window before liver 
colonization, initially within the ventral domain 
of the dorsal aorta (Godin and Cumano, 2002; 
Dzierzak and Speck, 2008; Medvinsky et al., 
2011). During the functional embryonic day 
(E) 11.5–12.5 period when the AGM region 
acts as an HSC organ, the number of definitive 
HSCs does not exceed one to three. However, 
the strong autonomous HSC generation poten-
tial of the AGM region can be unveiled in ex-
plant culture (Medvinsky and Dzierzak, 1996; 
Kumaravelu et al., 2002). Although the em-
bryonic endothelium is considered to be a source 
of definitive HSCs in the developing embryo 
(Zovein et al., 2008; Chen et al., 2009; Bertrand 
et al., 2010; Kissa and Herbomel, 2010), the 
exact details of this process remain unclear.
AGM explant cultures can be used to repli-
cate the formation of definitive HSCs in the 
embryo and have been useful in the understand-
ing of some mechanisms of HSC development 
(Medvinsky and Dzierzak, 1996; Cai et al., 2000; 
Robin et al., 2006); however, their usefulness 
for such analysis is limited. Development of an 
AGM reaggregation culture system allowed some 
essential hurdles to be overcome (Taoudi et al., 
2008). Introduction of a dissociation/reaggre-
gation step before culture enabled manipula-
tion of cells to be performed. During 4 d of 
culture, definitive HSCs undergo a 150-fold 
expansion in a stroma-dependent manner within 
three-dimensional AGM reaggregates. Using the 
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The aorta-gonad-mesonephros region plays an important role in hematopoietic stem cell 
(HSC) development during mouse embryogenesis. The vascular endothelial cadherin+ CD45+ 
(VE-cad+CD45+) population contains the major type of immature pre-HSCs capable of develop-
ing into long-term repopulating definitive HSCs. In this study, we developed a new coaggrega-
tion culture system, which supports maturation of a novel population of CD45-negative 
(VE-cad+CD45CD41+) pre-HSCs into definitive HSCs. The appearance of these pre-HSCs 
precedes development of the VE-cad+CD45+ pre-HSCs (termed here type I and type II 
pre-HSCs, respectively), thus establishing a hierarchical directionality in the developing 
HSC lineage. By labeling the luminal surface of the dorsal aorta, we show that both type I 
and type II pre-HSCs are distributed broadly within the endothelial and subendothelial 
aortic layers, in contrast to mature definitive HSCs which localize to the aortic endothelial 
layer. In agreement with expression of CD41 in pre-HSCs, in vivo CD41-Cre–mediated 
genetic tagging occurs in embryonic pre-HSCs and persists in all lymphomyeloid lineages of 
the adult animal.
© 2011 Rybtsov et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
1306 Development of hematopoietic stem cells | Rybtsov et al.
tive HSCs (Taoudi et al., 2005). In this study, coaggregation 
culture of the VE-cad+CD45 population with OP9 cells re-
sulted in the appearance of 11 definitive HSCs with long-
term multilineage engraftment potential per embryo equivalent 
(Fig. 1 E; Fig. 2, A, B, and E; and Fig. S2). Direct comparison 
confirmed the superior support of definitive HSC produc-
tion by OP9 cells than by complete AGM stroma (Fig. S1 E). 
Coaggregation of the VE-cad+CD45+ population with OP9 
cells gave only 4.8 HSCs per embryo equivalent (Fig. 2, C–E). 
Successful long-term multilineage engraftment was also ob-
served in secondary recipients (Fig. S2). Thus, these culture 
conditions facilitate the formation of definitive HSCs from a 
VE-cad+CD45 population that is distinct from previously 
identified VE-cad+CD45+ pre-HSCs. Real-time PCR analysis 
confirmed the lack of CD45 messenger RNA in the VE-
cad+CD45 population (Fig. S1 D). These experiments iden-
tify the VE-cad+CD45 cells in the E11.5 AGM region as 
embryonic ancestors of definitive HSCs that are capable of 
maturing into definitive HSCs during development.
In parallel experiments, we tested whether VE-cad+CD45 
pre-HSCs can be identified in the E11.5 yolk sac (YS) and 
the fetal liver (Fig. S2 C). None of the VE-cad+CD45 
reaggregation system, the population of vascular endothelial 
cadherin+ CD45+ (VE-cad+CD45+) pre-HSCs capable of ma-
turing into definitive HSCs has been identified (Taoudi et al., 
2008). On rare occasions, we observed the formation of HSCs 
from CD45 cells, which included VE-cad+CD45 endothelial 
cells. However, because of a possibility of contamination during 
sorting with the major VE-cad+CD45+ pre-HSC population, 
the existence of CD45 pre-HSCs in the AGM region re-
mained unclear. Given current views that HSCs derive from the 
embryonic endothelium (Zovein et al., 2008; Chen et al., 2009; 
Eilken et al., 2009; Lancrin et al., 2009; Bertrand et al., 2010; 
Boisset et al., 2010; Kissa and Herbomel, 2010), we have been 
looking for culture conditions that might favor the genera-
tion of definitive HSCs from the VE-cad+CD45 population.
In this study, we demonstrate that replacement of the com-
plete AGM microenvironment with a stromal OP9 line favors 
the development of definitive HSCs from the VE-cad+CD45 
cells, thus clearly identifying this population as pre-HSCs. 
However, the VE-cad+CD45 pre-HSCs are not true endo-
thelial cells as they are primed with a hematopoietic CD41 
marker. We also show that in contrast to definitive HSCs, 
which are localized to the endothelial lining, pre-HSCs are 
broadly distributed throughout the wall of the dorsal aorta. 
Thus, specification of the HSC lineage in the mouse embryo 
involves at least two preliminary hematopoietically primed mat-
uration steps. In accord with expression of CD41 on pre-HSCs, 
CD41-Cre genetically labels in vivo pre-HSCs and propor-
tionally the adult hematopoietic system. Based on phenotypic 
and spatial characterization of two classes of pre-HSCs and 
definitive HSCs, we propose a simple model for HSC devel-
opment in the AGM region.
RESULTS
Identification of the VE-cad+CD45 pre-HSC population  
in the AGM region
For this analysis, we purified three cell populations by 
FACS from the E10.5 (36–39 somite pairs) and E11.5 AGM 
region, (a) VE-cad+CD45+, (b) VE-cad+CD45, and (c) VE-
cadCD45+, and coaggregated them with OP9 cells (Fig. 1 A 
and Fig. S1). Coaggregates were produced by combining 1 ee 
(embryo equivalent) of each of these populations with 105 OP9 
cells using centrifugation in the pipette tip, and these were 
then cultured as described previously (Taoudi et al., 2008; 
Sheridan et al., 2009). Although definitive HSCs can be de-
tected by direct transplantation of freshly isolated cells, pre-HSCs 
must first mature into definitive HSCs in culture. Direct trans-
plantation of the E10.5 AGM region does not normally give 
hematopoietic repopulation (Müller et al., 1994); however, 
the VE-cad+CD45 fraction (only) gave rise to definitive HSCs 
in the coaggregate culture (Fig. 1, B and C). In line with pre-
vious results (North et al., 2002; Taoudi et al., 2005), the first 
definitive HSCs detectable by direct transplantation in the 
E11.5 AGM resided within the VE-cad+CD45+ population 
(Fig. 1 D). Using the complete E11.5 AGM reaggregation 
system, we previously identified the major VE-cad+CD45+ 
pre-HSCs as a population capable of maturation into defini-
Figure 1. Identification of VE-cad+CD45 pre-HSCs in the AGM 
region. (A) Experimental design. (B–E) E10.5 (B and C) or E11.5 (D and E) 
AGM regions were dissociated and sorted on the basis of CD45 and VE-
cad expression. Sorted cells were either directly transplanted (B and D) or 
allowed to mature in coaggregate cultures with OP9 cells for 4 d and then 
transplanted (C and E). Transplanted doses are 2 (C), 4 (D), and 0.2 ee (E) 
per recipient. Chimerism (percentage) indicates the proportion of donor-
derived cells in the blood of recipient animals. Data are derived from three 
independent experiments for each type of experiment in C–E. (B) *, see 
Muller et al. (1994). VC, VE-cad.
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One possible explanation for this is that VE-cad+CD45 pre-
HSCs are more immature and pass via an extra step to become 
HSCs. To test this directly, VE-cad+CD45 cells sorted to a 
high level of purity that excludes any significant presence of 
VE-cad+CD45+ cells (Fig. S3, A and B) were co-cultured with 
OP9 cells for 24 h. Cells derived from the VE-cad+CD45 
population were then repurified to obtain VE-cad+CD45+ 
and VE-cad+CD45 cell populations (Fig. 3 B, sorting II; 
and Fig. S3 C). These populations were again coaggregated 
with fresh OP9 cells and cultured for 4 d to allow them to 
complete maturation into definitive HSCs and then trans-
planted into irradiated recipients (Fig. S3, D and E). Impor-
tantly, the VE-cad+CD45 population (a) does not contain 
definitive HSCs (Figs. 1 B and 3 A; Taoudi et al., 2005) and 
(b) does not mature into definitive HSCs during the first 48 
h of co-culture (Fig. 3 A). Only the resorted VE-cad+CD45+ 
fraction but not the VE-cad+CD45 fraction matured into 
definitive HSCs by the end of the co-culture period (Fig. 3 B). 
Thus, within the first 24 h of co-culture with OP9 stroma, the 
initial VE-cad+CD45 pre-HSCs acquired the VE-cad+CD45+ 
(pre-HSC) phenotype. These experiments establish a hierar-
chy for the developing definitive HSC lineage within the AGM 
region, indicating that VE-cad+CD45 pre-HSCs mature into 
definitive HSCs via the intermediate VE-cad+CD45+ pre-
HSC phenotype. Based on these observations, we define 
VE-cad+CD45 and VE-cad+CD45+ cells as type I and type II 
pre-HSCs, respectively.
Type I pre-HSCs are CD41+/lowLin
To characterize type I pre-HSCs further, we included addi-
tional surface markers in our experiments. The VE-cad+CD45 
population contains endothelial cells and is highly enriched 
for vascular tubule–forming cells (Taoudi et al., 2005). Sur-
prisingly, however, we found that the VE-cad+CD45 popula-
tion also contains a proportion of cells that express B220, CD3e, 
and Ter119 (and less convincingly Mac1, CD4, and GR1), 
cumulatively called here Lin+ (Fig. S4). We tested whether 
the type I pre-HSCs reside within the VE-cad+CD45Lin+ or 
VE-cad+CD45Lin fraction (Fig. S4 A). After coaggrega-
tion and culture with OP9 cells, the cultures were assayed 
in the long-term repopulation assay, revealing that only the 
VE-cad+CD45Lin cells were capable of developing into 
definitive HSCs (Fig. S4, B and C).
We then investigated whether the type I pre-HSCs ex-
press CD41, a marker expressed in all hematopoietic progen-
itors in early embryos (Corbel and Salaün, 2002; Emambokus 
and Frampton, 2003; Mikkola et al., 2003), and a fraction 
of cells in E9.5–10.5 embryos that are capable of develop-
ing into adult HSCs upon injection into newborn recipients 
(Ferkowicz et al., 2003). Approximately 10% of cells within the 
VE-cad+CD45 population express CD41 at various levels 
(Fig. 4 A). The VE-cad+CD45 population was purified into 
(a) CD41high, (b) CD41low, and (c) CD41 fractions and cul-
tured in coaggregates with OP9 cells. We found that only the 
VE-cad+CD45CD41low population is capable of maturing into 
definitive HSCs. Truly endothelial VE-cad+CD45CD41 
populations purified from these sources gave rise to definitive 
HSCs after co-culture with OP9 stromal cells (Fig. 2 F). 1 out 
of 11 recipients transplanted with YS-derived VE-cad+CD45 
cells showed short-term repopulation at high level (19%), which 
disappeared by 3.5 mo after transplantation (not depicted).
VE-cad+CD45 pre-HSCs mature into definitive HSCs  
via the intermediate VE-cad+CD45+ pre-HSC phenotype
Subsequently, we studied the dynamics of the pre-HSC to de-
finitive HSC transition by transplanting coaggregates after 24, 
48, 72, and 96 h of culture into irradiated recipients (Fig. 3 A). 
We observed that VE-cad+CD45 cells matured into de-
finitive HSCs slightly slower than VE-cad+CD45+ pre-HSCs. 
Figure 2. Quantification of definitive HSCs in coaggregate cul-
tures of the E11.5 AGM region. (A, C, and E) Quantification of defini-
tive HSCs from coaggregate cultures using limiting dilution analysis. 
(A–D) HSC generation by the VE-cad+CD45 population (A and B) and 
the VE-cad+CD45+ population (C and D) is shown. 1 ee of the population 
of interest was aggregated with OP9 cells, and the resulting population 
was transplanted into each recipient (A, C, and E) at the indicated dose 
expressed in embryo equivalents (x axis). Each red dot represents one 
recipient mouse. (B and D) Kinetics of donor-derived blood chimerism 
upon transplantation of coaggregate cultures of VE-cad+CD45 (B) or 
VE-cad+CD45+ (D) populations. Each recipient mouse received 1 ee of 
donor-derived cells. Time after transplantation (months) is indicated.  
(F) Coaggregates were made with VE-cad+CD45 cells from E11.5 YS, 
fetal liver, and nonhematopoietic tissues (tail and somites) and trans-
planted (2 ee/recipient). Control coaggregates of the dorsal aorta were 
transplanted at 0.2 ee/recipient. Data are derived from three indepen-
dent experiments for each type of experiments in A–E and two indepen-
dent experiments for F. VC, VE-cad.
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microinjected 
into the lumen 
of dorsal aorta 
using a micro-
pipette for 30 s 
(Fig. 6, A and 
B; and Fig. S5). This allowed us to label aortic luminal endo-
thelial and hematopoietic cells and, to a lesser extent, the 
immediate subluminal cell layer but not the deeper underly-
ing mesenchyme (Fig. 6, C–F). All cells in intra-aortic clus-
ters were labeled, indicating that intercellular contacts are 
loose enough in intra-aortic clusters to allow OG penetra-
tion. The basal lamina underlying the endothelial lining is 
possibly a stronger barrier for OG penetration. After 30 s of 
labeling, a cell suspension was prepared, and OG-labeled and 
unlabeled cells were purified by FACS and directly trans-
planted into irradiated recipients (Fig. 6, G, H, J, and K). 
Donor repopulation was only observed in mice that received 
cells did not generate definitive HSCs (Fig. 4 B). An in vitro 
assay confirmed that, in contrast to the VE-cad+CD45CD41 
cells, the VE-cad+CD45CD41low fraction was devoid of the 
endothelial potential (Fig. 5), which is in agreement with 
previous observations that CD41 expression marks commitment 
to hematopoietic cells during development (Li et al., 2005; 
Hashimoto et al., 2007).
We then tested by direct transplantation whether CD41 
also marks definitive HSCs from freshly isolated AGM regions. 
In line with a previous study (McKinney-Freeman et al., 2009), 
we found that, with one exception, only recipients of CD41low 
cells were repopulated (Fig. 4, D and E), demonstrating that 
CD41 is indeed expressed on AGM definitive HSCs.
Type I and type II pre-HSCs are localized to both luminal 
and subluminal layers of the dorsal aorta
To determine the localization of the definitive HSCs and pre-
definitive HSCs, the fluorescent dye Oregon green (OG) was 
Figure 3. In the E11.5 AGM region, VE-
cad+CD45 (type I) pre-HSCs mature into defini-
tive HSCs via intermediate VE-cad+CD45+ (type II) 
pre-HSCs. (A) Time course of appearance of defini-
tive HSCs during 4 d of culture. In each experiment,  
1 ee of AGM cells was aggregated with OP9 cells  
and transplanted into each recipient at each time 
point. (B) Sorted VE-cad+CD45 cells co-cultured 
with OP9 cells for 24 h were resorted on the basis of 
VE-cad (VC) and CD45 expression. All four resorted 
populations were coaggregated with fresh OP9 cells 
and cultured for a further 96 h and transplanted 
separately into irradiated recipients (2 ee/recipient). 
Numbers of mice repopulated/transplanted are  
indicated. Data are derived from two independent 
experiments.
Figure 4. In the E11.5 AGM region, 
CD41 marks type I pre-HSCs and defini-
tive HSCs. (A) Gating strategy for fractionat-
ing the VE-cad+CD45 population into 
CD41high (R1, 46 ± 4/ee), CD41low (R2, 260 ± 
18/ee), and CD41 (R3, 2300 ± 110/ee) sub-
sets. R4 includes the VE-cadCD45CD41+ 
cell population. (B) Recipients were trans-
planted with sorted populations R1, R2, R3, 
and R4 after 4-d co-culture with OP9 cells 
(doses per recipient indicated). (C) AGM region 
immunostaining for type I pre-HSCs (VE-
cad+CD45CD41+). The boxed area within the 
top left image is shown at high magnification 
with individual stainings for VE-cad, CD41, or 
CD45 (top right). Merged images are shown 
for DAPI and VE-cad (bottom left) and VE-cad, 
CD41, and CD45 (bottom right). Arrowheads 
show subluminal localization of these cells. 
D↔V, dorsoventral orientation. Bar, 10 µm. 
(D) Gating strategy for subfractionating de-
finitive HSCs on the basis of CD41 expression. 
(E) VE-cad+CD45+ cells sorted on the basis of 
CD41 expression (high, R1; low, R2; and nega-
tive, R3) from the uncultured AGM region 
were directly transplanted into irradiated 
recipients (4 ee/recipient). The CD41low frac-
tion contained HSCs. Data are derived from 
three independent experiments for all experi-
ments. VC, VE-cad.
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of exact position of OG low cells below the luminal aortic 
layer may not be considered very accurate, except that they 
are located under the first luminal layer and that OG-negative 
cells must be localized comparatively deeper. Further con-
focal analysis revealed rare VE-cad+CD45CD41+ cells inte-
grated both in the luminal endothelial lining and intra-aortic 
clusters (unpublished data), which is in agreement with a recent 
study (Yokomizo and Dzierzak, 2010), and in the subluminal 
compartment of the dorsal aorta (Fig. 4 C and Fig. S6).
Previous analysis led us to a supposition that type II (VE-
cad+CD45+) pre-HSCs are organized predominantly in large 
intra-aortic clusters (Taoudi et al., 2008). Here, we found 
that both luminal (OG positive) and subluminal (OG nega-
tive) VE-cad+CD45+ cells were capable of developing into 
definitive HSCs in coaggregate cultures (Fig. 6 L). Accord-
ingly, confocal analysis demonstrated the presence of rare 
VE-cad+CD45+ cells, usually organized in small clusters, 
under the luminal surface of the dorsal aorta (Fig. S7). Thus, 
both type I and type II pre-HSCs are integrated not only in 
the luminal endothelial lining of the dorsal aorta, as was pro-
posed previously for type II pre-HSCs (Taoudi et al., 2008), 
but also within its deeper layers.
Expression of Cre from a CD41-driven transgene labels  
the adult hematopoietic system
CD41-Cre mice (Emambokus and Frampton, 2003) were 
crossed with silent GFP (sGFP) mice (Gilchrist et al., 2003), 
and recombination resulting in GFP expression was assessed 
in the adult hematopoietic system. Labeling of hematopoietic 
cells in these embryos was observed before onset of circula-
tion, beginning from E8 concurrently in preliver sites of hema-
topoiesis: the YS, allantois, and dorsal aorta (Figs. 7 and 8 A), 
which later harbor HSCs (Medvinsky et al., 2011). Inter-
estingly, labeling of cells in the allantois continued to its base 
and extends to the proximal part of the bifurcated dorsal aorta 
(Fig. 7 B). By E8.5, labeling of cells in the paired dorsal aorta 
spread further rostrally (Fig. 7 C). At E9.5–10.5, GFP+ cells 
actively circulated in the vascular system (Fig. 7, D and E; 
and not depicted). By E11.5, GFP+ cells colonized the liver 
(Fig. 7 F). In contrast to previous observations (Emambokus 
and Frampton, 2003), we found efficient (between 35 and 
60%) labeling of adult blood and hematopoietic tissues 
(Fig. 8 D). Incomplete tagging of adult blood with GFP 
suggests either variegated CD41-Cre transgene expression 
(Festenstein et al., 1996) or variable levels of CD41 expression 
in the developing HSCs. Flow cytometric analysis showed 
proportionate GFP labeling of lymphoid and myeloid compart-
ments (Fig. 8 E). Southern blot analysis confirmed that GFP-
negative blood and bone marrow cells lacked Cre-mediated 
deletion of the stop cassette (Fig. S8 B). Although GFP expres-
sion looks highly specific for blood in the embryo, we wanted 
to exclude the possibility of illegitimate expression of Cre re-
combinase in the endothelial population. Although real-time 
PCR analysis readily identified Cre message in sorted CD41+ 
cells, it was absent in VE-cad+CD45CD41 endothelial 
cells (Fig. S8 A).
transplants of VE-cad+CD45+OGhigh cells but not those trans-
planted with VE-cad+CD45+OG/low cells, indicating that 
definitive HSCs in the AGM region are localized to the en-
dothelial lining of the dorsal aorta (Fig. 6 K). This result is in 
agreement with previous data using Sca1-GFP reporter mice 
(de Bruijn et al., 2002).
We then determined whether type I pre-HSCs localized 
to the luminal endothelium of the dorsal aorta. To this end, 
purified VE-cad+CD45OGhigh, VE-cad+CD45OGlow, and 
VE-cad+CD45OG populations were coaggregated with 
OP9 cells to test their capacity to develop into definitive 
HSCs. Long-term repopulation assays showed that all three 
VE-cad+CD45 populations developed into definitive HSCs 
(Fig. 6 I). The intensity of OG staining determined by flow 
cytometry was correlated with staining on confocal images, 
thereby defining the localization of type I pre-HSCs within 
luminal, immediate subluminal, and deeper subluminal areas 
of the dorsal aorta (Fig. 6, E and F). However, the assessment 
Figure 5. Lack of endothelial activity in the VE-cad+CD41+ popu-
lation. (A–D) E10.5 (A and B) and E11.5 (C and D) AGM VE-cad+CD45 
populations were purified based on CD41 expression. Error bars show 
standard deviation of three independent sorting experiments. (A–F) He-
matopoietic (A, C, and E) and endothelial (B, D, and F) in vitro assays were 
set up in 96-well plates using single-cell deposition. (E and F) Hematopoi-
etic (E) and endothelial (F) colonies were stained for CD31 and CD45. DAPI 
was used to visualize nuclei. Arrows show OP9 cells used as feeders. Bars: 
(E, left) 200 µm; (E, right) 30 µm; (F and F) 25 µm. Bar graphs show abso-
lute number of hematopoietic colonies per embryo equivalent (HC/ee; A 
and C) or endothelial colonies per embryo equivalent (EC/ee; B and D). All 
data are derived from three independent experiments.
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Herbomel, 2010). Cells of the progenitor/HSC phenotype 
have been shown to migrate inside the aorta in slices of the cul-
tured AGM region (Boisset et al., 2010). Our present data 
using OG labeling of the luminal cell layer of the mouse 
dorsal aorta confirm the previously demonstrated luminal 
localization of definitive HSCs (de Bruijn et al., 2002). It is 
thought that intra-aortic clusters are a morphological mani-
festation of HSCs budding from the endothelial lining of the 
dorsal aorta (North et al., 1999; Zovein et al., 2008; Chen et al., 
2009). Recent identification of pre-HSCs (embryonic ancestors 
of definitive HSCs) localized to intra-aortic clusters accord-
ing to phenotypic criteria supports this idea (Taoudi et al., 
2008). Some studies, based on indirect evidence, proposed that 
definitive HSCs may originate from subendothelial layers of 
the dorsal aorta (North et al., 1999, 2002; Bertrand et al., 
2005). However, this idea has mainly been abandoned in favor 
of direct conversion of endothelial cells into definitive HSCs 
(e.g., Boisset et al., 2010).
Using an AGM reaggregation system, we previously found 
that pre-HSCs in the E11.5 AGM region capable of maturing 
into definitive HSCs coexpress both VE-cad and CD45. Large 
intra-aortic clusters containing VE-cad+CD45+ cells possess 
morphological features of active endothelial invagination into 
the lumen of the dorsal aorta (Taoudi et al., 2008). However, 
because these pre-HSCs express the principal hematopoietic 
marker CD45, they cannot be considered to be endothelial cells. 
Therefore, we have been looking to track the development 
CD41-Cre transgene expression labels type I pre-HSCs  
in the E11.5 AGM region
We tested whether CD41-Cre–mediated recombination 
occurs in pre-HSCs. To this end, we purified GFP+ and GFP 
fractions of VE-cad+CD45 cells from E11.5 AGM regions of 
CD41-Cre::sGFP embryos and coaggregated them with OP9 
stroma. After 4 d of culture, cells were transplanted into irradi-
ated adult recipients (Fig. 8 B). We found that both GFP and 
GFP+ fractions provided multilineage long-term engraftment. 
Of note, transplanted HSCs derived from GFP pre-HSCs kept 
generating nonrecombined lymphomyeloid progeny (Fig. 8 B). 
In contrast, GFP+ pre-HSCs gave rise to HSCs that contin-
ued long-term production of GFP+ lymphomyeloid cells in 
recipient animals. To determine whether Cre-mediated label-
ing of the type I pre-HSCs translates in vivo into labeling of 
fetal liver definitive HSCs, we purified GFP+ and GFP sub-
sets of the E16.5 fetal liver CD45+CD150+CD48Ter119 
population and tested them in a long-term repopulation assay. 
Both GFP+ and GFP cell fractions provided long-term multi-
lineage hematopoietic repopulation (Fig. 8 C).
DISCUSSION
A significant body of evidence indicates that the embryonic 
endothelium of the dorsal aorta is hematogenic (Jaffredo 
et al., 1998; Nishikawa et al., 1998a,b; Oberlin et al., 2002). 
Live imaging in zebra fish enabled endothelial-hematopoietic 
transition to be tracked (Bertrand et al., 2010; Kissa and 
Figure 6. Definitive HSCs are localized to 
the luminal aortic layer, and pre-HSCs are 
localized to both the endothelial and  
deeper subendothelial layers. (A and B) Whole-
mount preparation of the E11.5 AGM region 
labeled with OG. (C) Transverse section of  
OG-labeled E11.5 dorsal aorta (Ao). The intra-
aortic cluster is shown in the boxed area.  
(D and E) Zoomed image of this cluster and 
aortic endothelium labeled with OG (D) and 
counter staining with DAPI (E). Bars: (A and B) 
700 µm; (C) 50 µm; (D and E) 20 µm. (F) The 
intensity of fluorescence of cells labeled 1–5 
was assessed and plotted as a histogram. Error 
bars show standard deviations of intensity of 
fluorescence from five independent confocal 
images. (G and J) Gating strategy of VE-
cad+CD45 (G) and VE-cad+CD45+ (J) cell popu-
lations isolated from the E11.5 AGM region on 
the basis of OG labeling. (H, I, K, and L) Trans-
plantation of freshly isolated cells (H and K) 
and cells cultured in coaggregate with OP9 
stromal cells (I and L). R1, VE-cad+CD45OG 
cells. R2, VE-cad+CD45OGlow cells. R3, VE-
cad+CD45OGhigh cells. R4, VE-cad+CD45+OG 
cells. R5, VE-cad+CD45+OGlow cells. R6, VE-
cad+CD45+OGhigh cells. Dose transplanted was 4 
ee/recipient (H and K) and 1 ee/recipient (I and L). 
Data are derived from two (G–I) or three (J–L) 
independent experiments. VC, VE-cad.
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are marked by VE-cad, they are also marked by hematopoi-
etic markers, first by CD41 in type I pre-HSCs and slightly 
later by CD45 in type II pre-HSCs and definitive HSCs. 
Interestingly, CD41 expression was found in E9.5–10.5 em-
bryonic cells capable of long-term contribution into adult 
hematopoiesis upon transplantation into newborn recipients 
(Yoder et al., 1997; Ferkowicz et al., 2003). Our experiments 
demonstrate that the VE-cad+CD45CD41+ cells, in con-
trast to the VE-cad+CD45CD41 population, do not form 
endothelial colonies in vitro, which is in agreement with pre-
vious studies (Li et al., 2005; Hashimoto et al., 2007). The 
lack of endothelial potential and priming with the CD41 
hematopoietic marker shows that type I pre-HSCs are not 
endothelial cells.
One of us previously generated CD41-Cre mice and by 
crossing with silent Rosa26-LacZ mice reported extensive 
Cre-mediated labeling of embryonic but not adult blood 
(Emambokus and Frampton, 2003). In this study, we used 
sGFP reporter mice (Gilchrist et al., 2003) and found consid-
erable (35–65%) labeling of the adult hematopoietic system. 
It is likely that in the previous model a low level of LacZ 
expression in adult hematopoietic cells went unnoticed. GFP 
labeling is observed in type I pre-HSCs in the E11.5 AGM 
region in a ratio similar to the labeling of HSCs in the fetal 
liver and of the adult hematopoietic system. This confirms 
that type I pre-HSCs are true in vivo embryonic precursors 
of the adult hematopoietic system. Partial recombination in 
the hematopoietic system may be a result of a slightly lower 
level of CD41 expression in a fraction of pre-HSCs/definitive 
HSCs or because of variegated transgene expression (Festenstein 
et al., 1996).
of HSCs from true endothelial cells. The use of the complete 
AGM reaggregation system for this goal was problematic 
because, although on occasions we observed development 
of definitive HSCs from CD45 cells, these might have 
derived from contaminating VE-cad+CD45+ pre-HSCs (Taoudi 
et al., 2008).
By replacing the complex AGM microenvironment with 
the OP9 stromal cell line, we established conditions support-
ing the development of definitive HSCs predominantly from 
the VE-cad+CD45 population. It is possible that the new-
born origin of the OP9 line (Nakano et al., 1994) makes them 
competent to support efficient maturation of pre-HSCs. Our 
preliminary data show that selected cell lines from the AGM 
region can also support maturation of type I pre-HSCs into 
definitive HSCs (unpublished data). We explored the lineage 
hierarchy between two classes of pre-HSCs (VE-cad+CD45 
and VE-cad+CD45+) and definitive HSCs. Because defini-
tive HSCs in the early embryo are VE-cad+CD45+ (North 
et al., 2002; Taoudi et al., 2005), their maturation from 
VE-cad+CD45 pre-HSCs is likely to be accompanied by 
acquisition of the CD45 marker. Using a resorting and recul-
turing strategy, we established that the VE-cad+CD45 pre-
HSCs (type I) mature into the VE-cad+CD45+ pre-HSCs 
(type II) during the first 24 h of culture. This confirmed that 
type I pre-HSCs are more immature precursors of type II 
pre-HSCs.
Using intra-aortic labeling with fluorescent OG dye, we 
determined that, in contrast to definitive HSCs, a significant 
proportion of both classes of pre-HSCs are localized to deeper 
layers of the dorsal aorta. We also found that although at all 
maturation steps the HSC lineage starting from type I pre-HSCs 
Figure 7. Analysis of CD41-Cre::sGFP embryos. The developing HSC lineage passes through a CD41-positive stage in vivo. (A and A) E7.5 embryo.  
(B and B) E8.0 embryo. GFP+ cells in the YS are indicated by the arrowhead (B) and at the base of the allantois (BA), at the bifurcation of the paired dorsal 
aorta (Ao), and the allantois (Al) itself (B). (C and C) E8.5 embryo. GFP+ cells are within the blood island/belt (BB), allantois, and paired dorsal aorta (C) 
and within the body of the embryo dissected from the YS (C). (D and D) E9.5 embryo. GFP+ cells are in circulation in the dorsal aorta (arrowheads). Bl, 
blood coming out of the dissected embryo. (E and E) E10.5 embryo. GFP+ cells in the embryo vasculature. Arrowheads point to the dorsal aorta.  
(F and F) E11.5 embryo. GFP+ cells in the liver (FL). A, D, E, and F are fluorescent images; A, B, B, C, C, D, E, and F are fluorescent images merged with 
phase-contrast or brightfield images.
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origin of the HSC lineage (Eilken et al., 2009; Lancrin et al., 
2009; Kissa and Herbomel, 2010) but outlines a more com-
plex three-step scenario. Early priming of the HSC lineage with 
CD41 beginning from E9.5 (Ferkowicz et al., 2003) indicates 
that segregation of the HSC lineage from the endothelial 
compartment occurs well before the emergence of definitive 
HSCs in E11.5 embryos. However, the specification of the 
HSC lineage from the subendothelial Runx1-expressing 
mesenchyme cannot be excluded either (North et al., 1999, 
2002). Indicatively, the subaortic mesenchyme in amphibians 
exhibits expression of key hematopoietic transcription factors 
(SCL, Runx1, and Gata2; Ciau-Uitz et al., 2000). More 
complex scenarios are conceivable. For example, it cannot be 
excluded that the remodeling endothelial network beneath 
the dorsal aorta, including omphalomesenteric artery, is a 
source of subaortic pre-HSCs (Zovein et al., 2010). If so, 
pre-HSCs from these vessels migrate toward the dorsal aorta 
where they become definitive HSCs. Interestingly, we have 
not been able to detect type I pre-HSCs in the YS. Identifi-
cation of the developmental stage preceding the formation of 
type I pre-HSCs in the AGM region is an important issue 
that will pose a significant challenge for further research.
In summary, the identification of two classes of hemato-
poietically primed pre-HSCs, which are broadly distributed 
through the wall of the dorsal aorta, unveils a more complex 
picture of definitive HSC formation than a one-step model 
of HSC origin from the E11.5 aortic endothelium. Together 
with a previous publication (Ferkowicz et al., 2003), our data 
indicate that the definitive HSC lineage is hematopoietically 
primed from very early stages. The dispersed spatial distribu-
tion of pre-HSCs and restricted luminal location of definitive 
HSCs suggest centripetal migration of the maturing pre-HSC 
lineage from the subluminal area of the dorsal aorta before 
entry into circulation.
MATERIALS AND METHODS
Mice. Mice were maintained and bred in compliance with UK Home Of-
fice regulations. C57BL/6 (CD45.2/2) or C57BL/6-EGFP (Gilchrist et al., 
2003) were paired to generate embryos of appropriate stage. The morning of 
discovery of the vaginal plug was designated as day 0.5. E10.S embryos used 
were 36–39 somite pairs. E11.5 embryos used were 41–45 somite pairs. 
C57BL/6 (CD45.1/CD45.1) animals were used as recipients. All experi-
ments with animals were approved under a Project License granted by the 
Home Office (UK), University of Edinburgh Ethical Review Committee, 
and conducted in accordance with local guidelines.
FACS. E11.5 AGM regions were dissected and dissociated as previously de-
scribed (Medvinsky et al., 2008). The following antibodies (BD) were used 
for staining of cells: anti-CD45-FITC or anti-CD45-APC (clone 30-F11), 
anti-CD41-PE (clone MW30reg), and biotinylated anti–VE-cad (clone 
11.D4.1), followed by incubation with streptavidin-APC or PE. Cell popu-
lations were isolated using a MoFlo cell sorter (Cytomation). Hematopoietic 
lineage depletion was performed using a cocktail of antibodies (anti–mouse-
B220, -CD19, -CD4, -CD8, -CD3, -Mac1, -Gr1, and -Ter119 antibodies 
conjugated with PE). Anti–mouse VE-cad antibody was biotinylated accord-
ing to the manufacturer’s protocol (FluoReporter Mini-bio-XX; Invitrogen). 
Purity checks were performed on aliquots from the collected samples. Gating 
of negative populations was performed on the basis of isotype control stain-
ing (BD). In cases of three-color analysis, fluorescence minus one stainings 
The simplest model of HSC development emerging from 
our experiments suggests that hematopoietically committed 
type I pre-HSCs mature into type II pre-HSCs in both the 
subluminal and luminal layers of the dorsal aorta but that the 
final maturation step resulting in the formation of definitive 
HSCs occurs exclusively within the endothelial lining of the 
dorsal aorta (Fig. S8 C). This model suggests a temporary in-
tegration of the hematopoietically committed HSC lineage 
into the aortic endothelial layer by E11.5, perhaps facilitated 
by VE-cad expression (Breviario et al., 1995; Carmeliet et al., 
1999). Although previously discussed in the literature (North 
et al., 1999; North et al., 2002; Bertrand et al., 2005), this 
scenario has mainly been abandoned in favor of a direct one-
step appearance of definitive HSCs from the E10–11.5 aortic 
endothelium. Our model does not exclude the endothelial 
Figure 8. Level of CD41-Cre–mediated recombination throughout 
development. (A) GFP expression in the embryonic CD41+ population 
(gated on CD45 live cells). (B) GFP+VE-cad+CD45 and GFPVE-
cad+CD45 populations were purified from E11.5 AGM regions and co-
aggregated with OP9 cells. After 4 d of co-culture, 0.5 ee of donor-derived 
cells were transplanted per recipient (each recipient is represented by one 
bar). Analysis of donor-derived blood cells was performed at 3.5 mo. Data 
are derived from two experiments. (C) GFP+ and GFP subsets of 
CD150+CD45+CD48Ter119 cells were sorted from E16.5 fetal livers and 
transplanted (100 cells/recipient) directly after sorting. Donor-derived 
blood chimerism was assessed 3.5 mo after transplantation. Each bar 
represents one recipient. (D) Proportion of GFP+ cells (percentage) in 
blood and hematopoietic organs of adult CD41-Cre::sGFP animals.  
(E) Proportion of GFP+ cells (percentage) in different hematopoietic lin-
eages of adult bone marrow. LSK, lineage-negative cKit+Sca1+ cells. 
LSK150, LinSca1+cKit+CD48CD34low/CD150+ cells. Each experiment 
was replicated twice. Error bars show standard deviation (five mice).
JEM Vol. 208, No. 6 
Article
1313
(National Institutes of Health). Sections were fixed by cold acetone, rehy-
drated with PBS, and blocked by 20% FCS. Staining with goat anti–mouse 
CD45 (clone AF114; R&D Systems) and directly conjugated rat anti–mouse–
VE-cad–Alexa Fluor 647 (clone eBioBV13; BioLegend) was followed by 
incubation with secondary rabbit anti–goat IgG–Alexa Fluor 488 antibody 
(Invitrogen). After washing with PBS, the sections were incubated with non-
immune goat serum to block nonspecific binding followed by incubation with 
the goat anti–rat Ig–Alexa Fluor 633 (Invitrogen) and followed by further washing 
with PBS. After that the sections were incubated with Fc blocking reagent 
followed by fixation with 5% paraformaldehyde and incubation with anti–
mouse CD41-PE (clone MWreg30; BD). In some cases, instead of using goat 
anti–mouse CD45, directly conjugated rat anti–mouse CD45–Alexa Flour 488 
(clone 30-F11; BioLegend) was used. Sections were counterstained with DAPI.
OG 488 staining. Stock solution was prepared by dissolving 0.5 mM OG 
488 Cell Trace (Invitrogen) in 169 µl DMSO. To obtain 1-µM staining 
solution, 2 µl of stock was diluted in 1 ml PBS. We determined that 1-µM 
solution of OG optimally stained all cells in the AGM cell suspension during 
30 s (Fig. S5 A). Furthermore, all pre-HSCs were also labeled with 1 µM 
OG solution in cell suspension (Fig. S5 B). This concentration of OG was 
chosen for further experiments.
E11.5 embryos were decapitated immediately above forelimbs and cut 
through hind limbs to open the caudal part of the dorsal aorta. OG solution 
was injected by mouth micropipette into the dorsal aorta and washed out 
after 30 s by injection of PBS supplemented with 20% FCS. After that, the 
embryo was additionally washed, and the AGM region was dissected. After 
dissociation of the AGM region, the cells were stained with antibodies for 
flow cytometry. Intensity of fluorescence of OG on sections was measured 
using DM IRE2 software (Leica).
Online supplemental material. Fig. S1 shows E11.5 AGM cell sorting and 
typical purity of sorted populations. Fig. S2 shows multilineage long-term 
engraftment of primary and secondary recipients transplanted with defini-
tive HSCs developed from AGM E11.5 VE-cad+CD45 pre-HSCs (type I) 
after 4-d co-culture with OP9 cells. Fig. S3 shows that pre-HSC type I 
populations develop into pre-HSC type II populations before maturing into 
definitive HSCs. Fig. S4 shows that pre-HSCs are VE-cad+CD45Lin. 
Fig. S5 shows the titration of OG 488. Fig. S6 shows localization of candi-
date type I (VE-cad+CD45CD41+) cells in the dorsal aorta. Fig. S7 shows 
localization of candidate type II (VE-cad+CD45+) pre-HSCs in the dorsal 
aorta. Fig. S8 shows the characterization of CD41-Cre–mediated recombi-
nation. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20102419/DC1.
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